Health
Common anticoagulant drug could be repurposed to help alleviate Covid-19 infections – News-Medical.net
An international team of researchers led by the Universities of Keele and Liverpool, working with Public Health England, has found that the common anticoagulant…
An international team of researchers led by the Universities of Keele and Liverpool, working with Public Health England, has found that the common anticoagulant drug heparin inhibits the SARS-Cov2 virus spike protein, by reducing the virus’ ability to attach to human cells and infect them.
The research, published in the journalsThrombosis and HaemostasisandBritish Journal of Pharmacology, found that heparin interacts with the spike protein on the surface of coronavirus (SARS-CoV2), destabilizing…
-
Business19 hours agoWarning! These ASX 200 shares were just downgraded
-
Business12 hours agoMacquarie tips 14% upside for this ASX tech stock
-
Business12 hours agoThis ASX 200 media stock is storming 7% higher to 52-week highs. Here’s why.
-
Business17 hours ago2 monthly payers you’ll want to own in 2025 and beyond